a nonsignificant trendP =0.108
In the PS-matched cohort, statin therapy showed a nonsignificant trend toward reduced ISS incidence (10.2% versus 14.5%, P =0.108).
In the PS-matched cohort, statin therapy showed a nonsignificant trend toward reduced ISS incidence (10.2% versus 14.5%, P =0.108).